Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Philips

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Structure (London, England : 1993)|October 15, 1995
Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptideS S Narula, R W Yuan, S E Adams, et al.
Journal of Clinical Microbiology|February 22, 2008
Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999John F Bohnsack, April Whiting, Marcelo Gottschalk, et al.
The Journal of Infectious Diseases|March 14, 1998
Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infectionF Y Lin, J D Clemens, P H Azimi, et al.
The New England Journal of Medicine|April 21, 1994
A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research NetworkA A Fanaroff, S B Korones, L L Wright, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2000
Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998F Y Lin, P H Azimi, L E Weisman, et al.
American Journal of Obstetrics and Gynecology|May 12, 2001
The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal diseaseF Y Lin, R A Brenner, Y R Johnson, et al.
The Pediatric Infectious Disease Journal|August 1, 1998
Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research NetworkA A Fanaroff, S B Korones, L L Wright, et al.
The Journal of Infectious Diseases|August 6, 2004
Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogenFeng-Ying C Lin, Leonard E Weisman, Parvin H Azimi, et al.
Journal of Clinical Microbiology|April 7, 2006
Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective studyFeng-Ying C Lin, April Whiting, Elisabeth Adderson, et al.
The Journal of Infectious Diseases|September 28, 2001
Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology studyF Y Lin, J B Philips, P H Azimi, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Structure (London, England : 1993)|October 15, 1995
Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptideS S Narula, R W Yuan, S E Adams, et al.
Journal of Clinical Microbiology|February 22, 2008
Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999John F Bohnsack, April Whiting, Marcelo Gottschalk, et al.
The Journal of Infectious Diseases|March 14, 1998
Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infectionF Y Lin, J D Clemens, P H Azimi, et al.
The New England Journal of Medicine|April 21, 1994
A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research NetworkA A Fanaroff, S B Korones, L L Wright, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2000
Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998F Y Lin, P H Azimi, L E Weisman, et al.
American Journal of Obstetrics and Gynecology|May 12, 2001
The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal diseaseF Y Lin, R A Brenner, Y R Johnson, et al.
The Pediatric Infectious Disease Journal|August 1, 1998
Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research NetworkA A Fanaroff, S B Korones, L L Wright, et al.
The Journal of Infectious Diseases|August 6, 2004
Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogenFeng-Ying C Lin, Leonard E Weisman, Parvin H Azimi, et al.
Journal of Clinical Microbiology|April 7, 2006
Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective studyFeng-Ying C Lin, April Whiting, Elisabeth Adderson, et al.
The Journal of Infectious Diseases|September 28, 2001
Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology studyF Y Lin, J B Philips, P H Azimi, et al.
Pageof 10